Mental Health · Perinatal
GAD-7 Perinatal Anxiety Screen
The Generalized Anxiety Disorder 7-item screen (Spitzer 2006), with perinatal-tuned interpretation. 7 questions, 5 minutes. Endorsed by ACOG CPG #4 (2023) for perinatal anxiety screening alongside the PHQ-9 and EPDS.
Last reviewed 25 May 2026
Over the last 2 weeks, how often have you been bothered by…
Introduction
The Generalized Anxiety Disorder 7-item scale (GAD-7) is a brief self-report screen for anxiety developed by Spitzer, Kroenke, Williams and Löwe in 2006 (Arch Intern Med). It maps onto the core DSM-5 criteria for generalized anxiety disorder and is widely used in primary care globally. ACOG CPG #4 (2023) endorses it for perinatal anxiety screening alongside the PHQ-9 (for depression).
Background — why anxiety matters in pregnancy
About 24 % of pregnant women meet criteria for at least one anxiety disorder (Dennis 2017 Br J Psychiatry meta-analysis). That’s more common than gestational diabetes or preeclampsia, yet historically far less screened for. Untreated antenatal and postnatal anxiety has documented effects on:
- Maternal sleep and physical wellbeing.
- Partner relationships and family functioning.
- Infant attachment and early bonding.
- Long-term child cognitive and emotional development.
Conversely, treated perinatal anxiety has outcomes comparable to non-anxious controls. The screening exists because the treatment works.
How the screen is structured
Seven items, each asking how often over the past 2 weeks the respondent has been bothered by a core anxiety symptom: nervous / on edge, uncontrollable worrying, excessive worrying about different things, trouble relaxing, restlessness, irritability, and a sense of impending doom. Each scored 0-3. Total ranges 0-21.
How to interpret your result
- 0-4 — Minimal anxiety. No further action.
- 5-9 — Mild anxiety. In perinatal care, this band warrants a conversation with your provider; threshold ≥ 7 is the validated perinatal cutoff (Simpson 2014).
- 10-14 — Moderate anxiety. Clinical assessment recommended; CBT for anxiety is first-line treatment.
- 15-21 — Severe anxiety. Treatment is recommended; combined psychotherapy + medication typical.
Perinatal-specific cutoff (≥ 7)
Simpson 2014 found that the standard general-population GAD-7 cutoff of ≥ 10 missed clinically significant perinatal anxiety cases. In pregnancy, baseline somatic symptoms (restlessness from third-trimester discomfort, irritability from sleep disruption, worry about the baby) push score baseline up. The perinatal-tuned cutoff of ≥ 7 is more sensitive without sacrificing much specificity. Many perinatal mental-health services use ≥ 7 as their threshold for offering a referral conversation.
Common perinatal anxiety presentations
- Generalized anxiety disorder — excessive worry about many things; what GAD-7 directly screens.
- Pregnancy-focused anxiety — focused on baby’s health, miscarriage / stillbirth fear, fear of birth (tokophobia).
- Postpartum OCD — intrusive thoughts about harm to the baby, usually ego-dystonic and distressing (not action-tendencies). Different from postpartum psychosis. Responds well to specialist CBT.
- Panic disorder — sudden discrete panic attacks with physical symptoms.
- Birth-related PTSD — flashbacks, hypervigilance, avoidance following a traumatic birth experience. EMDR and trauma-focused CBT are evidence-based.
Treatment options
- CBT for anxiety — first-line. Available via IAPT (England), primary-care psychology (US), perinatal mental-health teams elsewhere.
- SSRIs — pregnancy- and lactation-compatible. Sertraline is most-studied in breastfeeding.
- Combination treatment — psychotherapy + medication for moderate-severe anxiety.
- Peer support — PANDAS (UK), Postpartum Support International (US), antenatal peer groups.
- Self-help — CBT-based apps (NHS-approved options exist in many countries), mindfulness apps with caution.
Limitations
- The GAD-7 is a screen, not a diagnosis. Confirmation requires clinical interview.
- Does not differentiate generalized anxiety from OCD, panic disorder, or PTSD — positive screens typically lead to a broader anxiety assessment.
- Some pregnancy-related somatic symptoms can elevate the score — clinicians interpret in context.
- Cultural differences in anxiety presentation may affect score validity.
Sources
- Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-7.
- Simpson W, Glazer M, Michalski N, et al. Comparative efficacy of the generalized anxiety disorder 7-item scale and the Edinburgh Postnatal Depression Scale as screening tools for generalized anxiety disorder in pregnancy and the postpartum period. Can J Psychiatry 2014.
- Dennis CL, Falah-Hassani K, Shiri R. Prevalence of antenatal and postnatal anxiety: systematic review and meta-analysis. Br J Psychiatry 2017;210:315-23.
- ACOG. Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (CPG #4). Obstet Gynecol 2023.
- USPSTF. Screening for Anxiety Disorders in Adults: Recommendation Statement. JAMA 2023.
- Furtado M, et al. Anxiety disorders in pregnancy and the postpartum period. J Affect Disord 2018.